Loading...
Integrated Diagnostics Holdings plc
IDHC.L•LSE
Healthcare
Medical - Diagnostics & Research
£0.36
£0.003(0.85%)
Integrated Diagnostics Holdings plc (IDHC.L) Financial Performance & Income Statement Overview
Review Integrated Diagnostics Holdings plc’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
38.74%
↑ 38.74%
Operating Income Growth
64.60%
↑ 64.60%
Net Income Growth
111.14%
↑ 111.14%
Operating Cash Flow Growth
188.52%
↑ 188.52%
Operating Margin
18.18%
↑ 18.18%
Gross Margin
36.77%
↑ 36.77%
Net Profit Margin
17.93%
↑ 17.93%
ROE
23.56%
↑ 23.56%
ROIC
12.81%
↑ 12.81%
Integrated Diagnostics Holdings plc (IDHC.L) Income Statement & Financial Overview
Review Integrated Diagnostics Holdings plc's (IDHC.L) income statement with detailed quarterly and annual figures.
| Metric | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $1.33B | $1.17B | $1.07B | $1.18B |
| Cost of Revenue | $830.62M | $742.32M | $682.11M | $702.04M |
| Gross Profit | $496.64M | $428.26M | $386.71M | $479.70M |
| Gross Profit Ratio | $0.37 | $0.37 | $0.36 | $0.41 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $200.54M | $116.91M | $194.98M | $188.21M |
| Operating Expenses | $281.93M | $190.65M | $224.43M | $185.58M |
| Total Costs & Expenses | $1.11B | $932.97M | $906.54M | $887.62M |
| Interest Income | $24.47M | $25.13M | $9.09M | $19.39M |
| Interest Expense | $39.78M | $38.77M | $0.00 | $0.00 |
| Depreciation & Amortization | $76.25M | $109.88M | $67.76M | $64.94M |
| EBITDA | $290.96M | $651.54M | $281.25M | $353.02M |
| EBITDA Ratio | $0.22 | $0.56 | $0.26 | $0.30 |
| Operating Income | $214.72M | $220.22M | $213.49M | $288.09M |
| Operating Income Ratio | $0.16 | $0.19 | $0.20 | $0.24 |
| Other Income/Expenses (Net) | -$30.23M | $282.68M | -$31.19M | -$13.37M |
| Income Before Tax | $184.48M | $502.89M | $153.19M | $274.72M |
| Income Before Tax Ratio | $0.14 | $0.43 | $0.14 | $0.23 |
| Income Tax Expense | $106.02M | $101.29M | $72.29M | $98.31M |
| Net Income | $112.98M | $417.59M | $108.92M | $177.79M |
| Net Income Ratio | $0.09 | $0.36 | $0.10 | $0.15 |
| EPS | $0.19 | $0.70 | $0.18 | $0.30 |
| Diluted EPS | $0.19 | $0.70 | $0.18 | $0.30 |
| Weighted Avg Shares Outstanding | $600.00M | $600.00M | $600.002M | $600.00M |
| Weighted Avg Shares Outstanding (Diluted) | $600.00M | $600.00M | $600.00M | $600.00M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan